Article

Carl Zeiss Meditec owns majority interest

Jena, Germany—Carl Zeiss Meditec AG has acquired 87.1% of IOLTech SA, the French ophthalmic surgery specialist Carl Zeiss Meditec has committed to taking over.

Jena, Germany-Carl Zeiss Meditec AG has acquired 87.1% of IOLTech SA, the French ophthalmic surgery specialist Carl Zeiss Meditec has committed to taking over.

The German company had acquired about 63% of the IOLTech shares from its former principal shareholder as of Feb. 1. About two-thirds of the remaining minority shareholders accepted Carl Zeiss Meditec's voluntary public takeover bid by April 5.

"The company considers this result of the takeover bid as a further successful milestone on Carl Zeiss Meditec's way to the complete takeover of IOLTech," Carl Zeiss Meditec announced.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.